Term ends Jul 11, 2034 · High confidence
20-year base term ends Jul 11, 2034
Held by Astellas US LLC
Filed Feb 21, 2022 as application 17/676,811 · Granted Nov 8, 2022
Base term, 20 years from filing
Today
2014
2034
Clock starts
Jul 11, 2014
Jul 11, 2014
Term ends
Jul 11, 2034
Jul 11, 2034
Granted
Nov 8, 2022
Nov 8, 2022
base term
fee events
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 11,273,171, to Jul 11, 2034. The term already ends on or before that date, so the cap shortened nothing.
1 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
8
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 1 of 2 maintenance fees is paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jul 11, 2014, when application 14/329,702, the earliest non-provisional in its chain, was filed (this one was filed Feb 21, 2022) | Jul 11, 2034 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 11,273,171) | resolves to Jul 11, 2034, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 2 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Jul 11, 2034 | High confidence |
This family
| Application 14/329,702 | Abandoned not computed | not computed |
| Application 15/144,429 | Abandoned not computed | not computed |
| Application 16/434,018 | Abandoned not computed | not computed |
| US 11,273,171 | In force Jul 2034 | Jul 2034 |
| US 11,491,176 | this patent Jul 2034 | Jul 2034 |
| Application 17/958,710 | Abandoned not computed | not computed |
| US 12,016,875 | In force Jul 2034 | Jul 2034 |
| Application 18/132,253 | Abandoned not computed | not computed |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Aug 5, 2022 Reel 61088, frame 48 | Iveric Bio, Inc. | Hercules Capital, Inc. | Security Interest |
| Jun 26, 2023 Reel 64064, frame 579 | Patel, Samir; Everett, Richard; Brooks, Douglas; Tian, Shane Xinxin | Ophthotech Corporation | Assignment of Assignor's Interest |
| Jun 26, 2023 Reel 64111, frame 731 | Ophthotech Corporation | Iveric Bio, Inc. | Change of Name |
| Jul 17, 2023 Reel 64286, frame 472 | Hercules Capital, Inc. | Iveric Bio, Inc.; Iveric Bio Gene Therapy LLC; Orion Ophthalmology LLC | Release of Security Interest |
| Jul 17, 2023 reel/frame not recorded | Hercules Capital, Inc. | Iveric Bio, Inc. | Release of Security Interest |
| Jul 17, 2023 reel/frame not recorded | Hercules Capital, Inc. | Iveric Bio Gene Therapy LLC | Release of Security Interest |
| Jul 17, 2023 reel/frame not recorded | Hercules Capital, Inc. | Orion Ophthalmology LLC | Release of Security Interest |
| Jun 26, 2024 Reel 67851, frame 643 | Iveric Bio, Inc. | Astellas US LLC | Merger |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Jul 2034
Term ends Jul 11, 2034. Maintenance fees still fall due before then
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 11,273,171, ends no earlier than this term, so it caps nothing.
Citations
1
later US patent cites this one
That is below the median of utility patents granted in 2022 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.